Document is current
Any future updates will be listed below
-
Authors
Dan, Qingyun https://orcid.org/0000-0002-3110-9450
Chiu, Yan
Lee, Namil https://orcid.org/0009-0000-0382-8741
Pereira, Jose Henrique
Rad, Behzad https://orcid.org/0000-0001-6531-9168
Zhao, Xixi
Deng, Kai https://orcid.org/0000-0003-2937-8931
Rong, Yiou
Zhan, Chunjun
Chen, Yan https://orcid.org/0000-0002-1125-313X
Cheong, Seokjung
Li, Chenyi https://orcid.org/0000-0001-8294-1880
Gin, Jennifer W.
Rodrigues, Andria
Northen, Trent R. https://orcid.org/0000-0001-8404-3259
Backman, Tyler W. H. https://orcid.org/0000-0002-6056-353X
Baidoo, Edward E. K.
Petzold, Christopher J.
Adams, Paul D. https://orcid.org/0000-0001-9333-8219
Keasling, Jay D. https://orcid.org/0000-0003-4170-6088
-
Funding
Funding for this research was provided by:
U.S. Department of Energy (DE-AC02-05CH11231)
- License Information
-
More Information
Article History
Received: 22 November 2023
Accepted: 16 January 2025
First Online: 11 February 2025
Competing interests
: J.D.K. has financial interests in Ansa Biotechnologies, Apertor Pharma, Berkeley Yeast, BioMia, Cyklos Materials, Demetrix, Lygos, Napigen, ResVita Bio and Zero Acre Farms. The other authors declare no competing interests. Lawrence Berkeley National Laboratory and the University of California have filed a US provisional patent (serial number 63/645,806, pending approval) on the use of rimocidin PKS, TRs and cognate enzymes for bioproduction. Q.D., N.L., Y. Chiu and J.D.K. are the listed inventors.
